Navigation Links
Generation in Medical Technology
New LifeShirt(R) to Address Data and Usability Gaps in Remote Patient Monitoring Market
VENTURA, Calif., June 8 /PRNewswire/ -- VivoMetrics, Inc., a leading innovator in remote patient monitoring (RPM), announced today the first complete prototype of their next generation LifeShirt for the re...
WASHINGTON, June 3 /PRNewswire-USNewswire/ -- To foster and support the next generation of lupus researchers, the Lupus Foundation of America (LFA), Inc. has awarded summer fellowships to five young investigators who will conduct their studies under the supervision of an established lupus investig...
WILMINGTON, N.C., Jan. 13 /PRNewswire/ -- Inclinix, Inc., a clinical trial enrollment solutions provider, announces the release of its next generation Critical Population Research(R) (CPR) system. A proprietary technology that integrates numerous public and private databases, CPR analyzes each...
PRINCETON, N.J., Dec. 8 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) announced today results from a preclinical study for MDX-1401, a second-generation non-fucosylated version of MDX-060 that targets CD30, a marker for activated lymphocytes that is present on the malignant cells of Ho...
- Once-a-Day Radezolid Clinically and Microbiologically As Effective As Twice-a-Day Linezolid When Used to Treat a Variety of uSSSIs - NEW HAVEN, Conn., Oct. 26 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery, devel...
ZFN Technology has Broad Applications in Research, Drug Development and Therapeutics ST. LOUIS and RICHMOND, Calif., March 24 /PRNewswire-FirstCall/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL ) and Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today the pub...
- Tyrima Demonstrates Good Safety Profile and Excellent Pharmacokinetic Properties - RESEARCH TRIANGLE PARK, N.C., March 13, 2007 /PRNewswire/ -- CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today ...
BARCELONA, Spain--(BUSINESS WIRE)--May 22, 2007 - Professor Ian Meredith, M.D., Monash Medical Centre, Melbourne, Australia, on Tuesday presented positive nine-month results from the Medtronic RESOLUTE clinical trial at the EuroPCR meeting in Barcelona, Spain, with data showing a low number of adve...
...r returns to living independently. About Radius (www.radiuspharm.com) Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women's health. Radius has raised $106.5 million in private equity financing since its establishment in 2003 an...
...iabetes, cancer and cardiovascular disease. Mercury is focusing its internal AMPK drug development program for indications in oncology. Mercury's lead generation platform is based on a proprietary technology that enables the discovery and development of novel compounds that directly activate AMPK, a key regulat...
...eatment of hepatitis C (HCV). PSI-7851 is a second generation nucleotide polymerase inhibitor of HCV. P...efficacy and safety data with PSI-7851, our second generation nucleotide analog," said Michelle Berrey, MD, MPH,...mately 15-fold more potent than Pharmasset's first generation nucleoside polymerase inhibitor, RG7128 (formerly ...
... announced results from a Phase 1 cardiac safety study of picoplatin, a new generation platinum-based chemotherapy agent and the Company's lead product candidate....erence later this year. About Picoplatin Picoplatin is a new generation platinum-based chemotherapy agent that is in clinical development for multi...
...s in its pivotal Phase III trial for edoxaban in patients with atrial fibrillation. The Phase III study, Effective Anticoagulation with Factor Xa Next generation in Atrial Fibrillation (ENGAGE-AF), is comparing edoxaban with warfarin (INR2-3) for the prevention of stroke and systemic embolic events (SEE) in pat...
...Advisors, LLC and employees. It was founded in 1999 to develop the breakthrough MR guided Focused Ultrasound technology and transform it into the next generation operating room. Headquartered near Haifa, Israel, the company has over 160 employees and has invested more than $150 million in research, development,...
...d be developed for rheumatoid arthritis as well." Thiarabine is a next generation nucleoside analogue that Access has licensed from Southern Research. It has...ogenesis factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog which has demonstrated both pre-clinical and clinical act...
...ent with Genentech, Inc., a wholly-owned member of the Roche Group, for the generation of cell lines with novel characteristics for pharmaceutical protein product...pproach obviates the need for selection markers, thereby enabling the rapid generation of cell lines in which multiple genes have been knocked out. Our proven ab...
...ipated in the funding round. "With this round of financing we have secured all the funding needed for our entrance into the market as the second generation of diagnostic testing, a disruptive technology platform that promises accurate, point-of-care results and comes at a lower cost than the industry stan...
... About Pollogen: Pollogen Ltd. develops, manufactures and markets professional medical aesthetic devices, powered by the TriPollar(TM) 3rd generation Radio Frequency (RF) technology. Invented and perfected by Pollogen, proprietary TriPollar(TM) technology powers a full line of clinically-proven, non...
... Second generation Oxazolidinone Demonstrates Safety and Efficacy with Once-Daily, 200 milligr...istant pathogens. The company's lead drug candidate, torezolid, is a second generation oral and IV oxazolidinone antibiotic with potent activity against drug-resi...
...ndoVascular Forum's commitment to developing a new generation of tools for physicians to learn from peer experie...orm a complementary, accelerated path to knowledge generation and dissemination. "The end goal of this partnersh...ation ( www.ICSciences.com ). The EVF NGHI (next generation health Internet) community comes together to share...
...uct development programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Valortim(R) - ... RypVax(TM) - a recombinant dual antigen vaccine for plague A third generation rPA anthrax vaccine. For more information about PharmAthe...
... About Pollogen: Pollogen Ltd. develops, manufactures and markets professional medical aesthetic devices, powered by the TriPollar(TM) 3rd generation Radio Frequency (RF) technology. Invented and perfected by Pollogen, proprietary TriPollar(TM) technology powers a full line of clinically-proven, non...
...r. Our worldwide research in oncology includes collaborations with more than 160 cancer centers. GSK is closing in on cancer from all sides with a new generation of patient-focused cancer treatments in prevention, supportive care, chemotherapy, and targeted therapies. GSK's BioPharm R&D division has ...
...mparable clinical benefit to oxaliplatin but with significantly less neurotoxicity." Picoplatin, the Company's lead product candidate, is a new generation platinum-based chemotherapy agent. Clinical studies to date suggest that picoplatin has an improved safety profile. It is in clinical development for ...
WASHINGTON, June 3 /PRNewswire-USNewswire/ -- To foster and support the next generation of lupus researchers, the Lupus Foundation of America (LFA), Inc. has awarded summer fellowships to five young investigators who will conduct their studies under the supervision of an established lupus investig...
Facet Solutions, Inc. Expands U.S. Pivotal Study With Next Generation Implant System
HOPKINTON, Mass., April 27 /PRNewswire/ -- Facet Solutions, Inc. today announced that it has expanded its Pivotal Study to 12 sites in the United States. The ACADIA(TM) Facet Replacement Pivotal Study for the treatment of lumbar spinal stenosis utilizes the second generation design technology from...Next Generation Proton Therapy System for Cancer Treatment Set for Release This Year
LITTLETON, Mass., Feb. 26 /PRNewswire/ -- Still River Systems announced today the successful operation of the world's highest field, high energy cyclotron magnet. Still River's magnet is the key technical element for reducing the size and cost of the particle accelerator that will deliver proton t...Pieris Reports Development Progress for Anticalin(R) PRS-050, a Next Generation VEGF Antagonist
FREISING-WEIHENSTEPHAN, Germany, February 3 /PRNewswire/ -- Pieris AG, a biopharmaceutical company developing Anticalins(R), a novel class of targeted human protein therapeutics, reports today that it has made significant progress in the development of its Anticalin(R) candidate PRS-050, a pot...WILMINGTON, N.C., Jan. 13 /PRNewswire/ -- Inclinix, Inc., a clinical trial enrollment solutions provider, announces the release of its next generation Critical Population Research(R) (CPR) system. A proprietary technology that integrates numerous public and private databases, CPR analyzes each...
PRINCETON, N.J., Dec. 8 /PRNewswire-FirstCall/ -- Medarex, Inc. (Nasdaq: MEDX ) announced today results from a preclinical study for MDX-1401, a second-generation non-fucosylated version of MDX-060 that targets CD30, a marker for activated lymphocytes that is present on the malignant cells of Ho...
- Once-a-Day Radezolid Clinically and Microbiologically As Effective As Twice-a-Day Linezolid When Used to Treat a Variety of uSSSIs - NEW HAVEN, Conn., Oct. 26 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery, devel...
ZFN Technology has Broad Applications in Research, Drug Development and Therapeutics ST. LOUIS and RICHMOND, Calif., March 24 /PRNewswire-FirstCall/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL ) and Sangamo BioSciences, Inc. (Nasdaq: SGMO ) announced today the pub...
Beaumont Patients 1st to get Next Generation of Radiation Treatment
ROYAL OAK, Mich., Sept. 20 /PRNewswire/ -- Cancer patients at Beaumont Hospitals are the first in the world to be treated with the next generation of radiation therapy that is painless, faster, more accurate and precise than other treatments. Beaumont doctors and physicists invented and paten...- Tyrima Demonstrates Good Safety Profile and Excellent Pharmacokinetic Properties - RESEARCH TRIANGLE PARK, N.C., March 13, 2007 /PRNewswire/ -- CeNeRx BioPharma, Inc., a clinical stage company developing and commercializing innovative treatments for diseases of the central nervous system, today ...
Labtec’s Next Generation Pain Patch Successful in Clinical Studies
LANGENFELD, Germany, April 25, 2007-Labtec GmbH (Langenfeld, Germany), a specialty pharmaceutics company announces positive results from a multiple dose clinical study for their proprietary Sufentanil transdermal patch. “Today, we are pleased to announce the successful completion of the se...BARCELONA, Spain--(BUSINESS WIRE)--May 22, 2007 - Professor Ian Meredith, M.D., Monash Medical Centre, Melbourne, Australia, on Tuesday presented positive nine-month results from the Medtronic RESOLUTE clinical trial at the EuroPCR meeting in Barcelona, Spain, with data showing a low number of adve...
...r returns to living independently. About Radius (www.radiuspharm.com) Radius is a leading company in the discovery and development of a new generation of drug therapies for osteoporosis and women's health. Radius has raised $106.5 million in private equity financing since its establishment in 2003 an...
...iabetes, cancer and cardiovascular disease. Mercury is focusing its internal AMPK drug development program for indications in oncology. Mercury's lead generation platform is based on a proprietary technology that enables the discovery and development of novel compounds that directly activate AMPK, a key regulat...
Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
... Angiolix(R), a humanized monoclonal antibody which acts as an anti-angiogenesis factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog which has demonstrated both pre-clinical and clinical activity in certain cancers. For additional information on Access Pharmaceutic......eatment of hepatitis C (HCV). PSI-7851 is a second generation nucleotide polymerase inhibitor of HCV. P...efficacy and safety data with PSI-7851, our second generation nucleotide analog," said Michelle Berrey, MD, MPH,...mately 15-fold more potent than Pharmasset's first generation nucleoside polymerase inhibitor, RG7128 (formerly ...
Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology
...ally modified animal models of human disease. ZFN technology will make the generation of such animals faster and will create new opportunities in species other t...nerates transgenic rats using DNA or lentiviral vector microinjection. The generation of transgenic rats also is open to the scientific community through an open...... announced results from a Phase 1 cardiac safety study of picoplatin, a new generation platinum-based chemotherapy agent and the Company's lead product candidate....erence later this year. About Picoplatin Picoplatin is a new generation platinum-based chemotherapy agent that is in clinical development for multi...
...s in its pivotal Phase III trial for edoxaban in patients with atrial fibrillation. The Phase III study, Effective Anticoagulation with Factor Xa Next generation in Atrial Fibrillation (ENGAGE-AF), is comparing edoxaban with warfarin (INR2-3) for the prevention of stroke and systemic embolic events (SEE) in pat...
...Advisors, LLC and employees. It was founded in 1999 to develop the breakthrough MR guided Focused Ultrasound technology and transform it into the next generation operating room. Headquartered near Haifa, Israel, the company has over 160 employees and has invested more than $150 million in research, development,...
...d be developed for rheumatoid arthritis as well." Thiarabine is a next generation nucleoside analogue that Access has licensed from Southern Research. It has...ogenesis factor and is targeted to breast cancer; and Thiarabine , a new generation nucleoside analog which has demonstrated both pre-clinical and clinical act...
...ent with Genentech, Inc., a wholly-owned member of the Roche Group, for the generation of cell lines with novel characteristics for pharmaceutical protein product...pproach obviates the need for selection markers, thereby enabling the rapid generation of cell lines in which multiple genes have been knocked out. Our proven ab...
New Therapy Found to Prevent Heart Failure
... 5.7 million Americans , and the results were very positive. Patients with heart disease have a risk of arrhythmias and heart failure. The new generation of cardiac resynchronization therapy defibrillators (CRT-Ds) was designed to stop dangerous, life-threatening heart rhythms and improve the heart's co......ipated in the funding round. "With this round of financing we have secured all the funding needed for our entrance into the market as the second generation of diagnostic testing, a disruptive technology platform that promises accurate, point-of-care results and comes at a lower cost than the industry stan...
... About Pollogen: Pollogen Ltd. develops, manufactures and markets professional medical aesthetic devices, powered by the TriPollar(TM) 3rd generation Radio Frequency (RF) technology. Invented and perfected by Pollogen, proprietary TriPollar(TM) technology powers a full line of clinically-proven, non...
... Second generation Oxazolidinone Demonstrates Safety and Efficacy with Once-Daily, 200 milligr...istant pathogens. The company's lead drug candidate, torezolid, is a second generation oral and IV oxazolidinone antibiotic with potent activity against drug-resi...
New Study Showed Lantus(R) Plus One, Two or Three Shots of Apidra(R) Lowered Patients' Blood Sugar
...re information, www.sanofi-aventis.us or www.sanofi-aventis.com * Based on TRx data from IMS Health, National Prescription AuditTM (Next generation Prescription Methodology). Time period: May 2003 to February 2009. (C) 2009 sanofi-aventis U.S. LLC U.S. Contact: Carrie Meli...Access Pharmaceuticals Announces Publication of Thiarabine Combination Data
...ailable for download from the journal's website. "Thiarabine is a next generation nucleoside analogue, licensed by Access from Southern Research Institute ...i-angiogenesis factor and is targeted to breast cancer. Thiarabine is a new generation nucleoside analog which has demonstrated both pre-clinical and clinical act...Pharmasset to Present at Goldman Sachs and Needham Healthcare Conferences
...tiated a Phase 2b clinical trial in combination with Pegasys plus Copegus through a strategic collaboration with Roche; PSI-7851, an unpartnered, next generation HCV nucleotide analog, which recently began Phase 1 clinical studies and Racivir, for the treatment of HIV that has completed a Phase 2 clinical trial...Dow AgroSciences, World Wide Wheat Agree to Collaborate on Wheat
...wheat germplasm and robust breeding capabilities. Dow AgroSciences' experience in seed and trait commercialization will be leveraged to bring the next generation of wheat to market. W3 brings more than 40 years of plant breeding to the collaboration and will be able to leverage Dow AgroSciences' reach in key gl......ndoVascular Forum's commitment to developing a new generation of tools for physicians to learn from peer experie...orm a complementary, accelerated path to knowledge generation and dissemination. "The end goal of this partnersh...ation ( www.ICSciences.com ). The EVF NGHI (next generation health Internet) community comes together to share...
...uct development programs include: SparVax(TM) - a second generation recombinant protective antigen (rPA) anthrax vaccine Valortim(R) - ... RypVax(TM) - a recombinant dual antigen vaccine for plague A third generation rPA anthrax vaccine. For more information about PharmAthe...
... About Pollogen: Pollogen Ltd. develops, manufactures and markets professional medical aesthetic devices, powered by the TriPollar(TM) 3rd generation Radio Frequency (RF) technology. Invented and perfected by Pollogen, proprietary TriPollar(TM) technology powers a full line of clinically-proven, non...
AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis
...er stage ALS patients with poor respiratory function can be seen to benefit from the medication under double-blind conditions. AIMSPRO is a new generation biological medicine which is sourced and manufactured in Australia. It is derived from hyperimmune caprine serum and is currently under Phase II trial......r. Our worldwide research in oncology includes collaborations with more than 160 cancer centers. GSK is closing in on cancer from all sides with a new generation of patient-focused cancer treatments in prevention, supportive care, chemotherapy, and targeted therapies. GSK's BioPharm R&D division has ...
...mparable clinical benefit to oxaliplatin but with significantly less neurotoxicity." Picoplatin, the Company's lead product candidate, is a new generation platinum-based chemotherapy agent. Clinical studies to date suggest that picoplatin has an improved safety profile. It is in clinical development for ...
Kinex Pharmaceuticals To Present at ASCO 2009 Annual Meeting
...e-changing advances in cancer prevention and treatment. Kinex Pharmaceuticals is a drug discovery and development company that is focused on next generation drugs to treat cancer and immuno-inflammatory diseases. The Company has utilized its platform technologies to identify highly selective inhibitors of...Stand Up To Cancer Awards $73.6 Million for Novel, Groundbreaking Cancer Research
...tand Up To Cancer Innovative Research Grants Fund Early Career Scientists The SU2C Innovative Research Grants are an effort to support the next generation of extraordinary leaders in their quest to conquer cancer. These grants will provide up to $750,000 over a three-year term, and will be awarded to ear...Scientific Data Relating to Cinryze(TM) Presented at 6th Annual C1 Inhibitor Deficiency Workshop
...mples of plasma from nine HAE patients experiencing an attack in ViroPharma/Lev's Phase 3 CHANGE (C1 inhibitor in Hereditary Angioedema Nanofiltration generation evaluating Efficacy) trial; Samples of plasma were obtained from nine HAE patients at baseline, during an attack of swelling, and at one, fo...Other TagsOther Contents
(Date:5/24/2013)... Cancer cells spread and grow by avoiding detection and ... system can help to eliminate cancer cells; however, there ... ignore cancer cells. Regulatory T cells are immune cells ... this issue of the Journal of Clinical Investigation ... found that regulatory T cells that infiltrate tumors express ...
(Date:5/24/2013)... water scientists from around the world today issued a ... span of one or two generations, the majority of ... under the handicap of severe pressure on fresh water, ... no substitute. This handicap will be self-inflicted and is, ... to chronic underlying problems led by mismanagement and sent ...
(Date:5/23/2013)... ships per year, carrying more than 284 million tons of ... billion dollars in toll fees for the Panama Canal Authority. ... gallons of water are used from Gatun Lake, which is ... living in the isthmus. , However, the advent of ... of the ships at sea, has demanded change. The Panama ...
Breaking Biology News(10 mins):A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 2A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 3A majority on Earth face severe self-inflicted water woes within 2 generations: Scientists 4Reforestation study shows trade-offs between water, carbon and timber 2Reforestation study shows trade-offs between water, carbon and timber 3(Date:5/24/2013)... (PRWEB) May 24, 2013 A recent study ... of America dreads the upcoming bathing suit season. Almost 138 ... the weather heats up due to weight issues and a ... mercury rises. PharmaCo Labs recommends that those anxious about ... PhenObestin 37.5 as part of an overall effort to improve ...
(Date:5/24/2013)... myMEDholiday.com, a popular medical tourism portal which ... important medical travel destinations in Asia, has added a ... ensure a safe and successful trip for anyone planning ... tips on cost-savings, how to find the appropriate doctors ... wealth other essential advice. , A top-level marketing representative ...
(Date:5/24/2013)... Range Kleen Mfg. strives to “TCOTC.” Our ... from the President's desk to the Shipping Dock.” We hold ... and having passion while creating excellence and quality being results ... to do the right thing and what better way to ... by devastation. , Throughout the year Range Kleen donates to ...
(Date:5/24/2013)... May 24, 2013 This week is ... and their efforts to provide the best emergency care ... of this week is also to educate the public ... of survival. Citizens are the first link, and a ... proper bystander CPR after a cardiac arrest can triple ...
(Date:5/24/2013)... FRIDAY, May 24 (HealthDay News) -- Patients hospitalized for ... if they,re admitted on Mondays or in the morning, ... of stay are highest among heart failure patients admitted ... researchers, who are scheduled to present their findings Saturday ... Failure Association of the European Society of Cardiology. ...
Breaking Medicine News(10 mins):Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 2Health News:PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful 3Health News:myMEDholiday.com Introduces International Patient Guide to Assist People Planning Treatment Abroad 2Health News:Range Kleen Partners with Berndes in Red Cross Promotion: Taking Care of Oklahoma 2Health News:Acadian Medics Reunite with Miracle Baby 2Health News:Monday Best Time for Hospitalization With Heart Failure, Study Says 2[0] PhenObestin 37.5 Can Help Make Bathing Suit Season Less Stressful[0] myMEDholiday.com Introduces International Patient Guide to Assist People Planning Treatment Abroad[0] Range Kleen Partners with Berndes in Red Cross Promotion: Taking Care of Oklahoma[0] Acadian Medics Reunite with Miracle Baby[0] Monday Best Time for Hospitalization With Heart Failure, Study Says
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |